| 영문 | vaccine | 한글 | 백신 |
|---|---|---|---|
| 설명 | 전염병에 대하여 인공적으로 면역을 주기 위해 생체에 투여하는 항원의 하나. 병원체 및 독소에 대한 방어기구를 강화할 목적으로 사용되는 미생물제제를 말한다. 프랑스의 미생물학자 L. 파스퇴르에 의하여 제창된 용어로서, 어떤 감염증에 대하여 인공적으로 면역을 얻기 위하여 그 병원 미생물 또는 그 독소액에 적당한 조작을 가하여 만든 것을 말한다. |
||
| DEV | Duck Embryo Vaccine |
|---|---|
| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; B형 헤모필루스 인플루엔자 피막 다당질 백신... |
| HDCV | Human Diploid Cell Vaccine; 인간 이배체 세포 백신 |
| NTV | Nervous Tissue Vaccine; 신경 조직 백신 |
| OPV | Oral Polio-Vaccine; 경구용 소아마비 백신 |
| BPV | Bordatella pertussis vaccine |
|---|---|
| DTP | Diphtheria-tetanus-pertussis vaccine |
| Hib | Haemophilus influenzae type b vaccine |
| HDCV | Human Diploid Cell Vaccine |
| IPV | Inactivated Polio-Vaccine |
| villonodular pigmented tenosynovitis | A condition resembling pigmented villonodular synovitis but arising in periarticular soft tissue rather than in joint synovia; occurs most commonly in the hands. Synonym: villonodular pigmented tenosynovitis. (05 Mar 2000) |
|---|---|
| villous tenosynovitis | A condition resembling pigmented villonodular synovitis but arising in periarticular soft tissue rather than in joint synovia; occurs most commonly in the hands. Synonym: villonodular pigmented tenosynovitis. (05 Mar 2000) |
| dermatitis-arthritis-tenosynovitis syndrome | <syndrome> Disseminated infection with Neisseria gonorrhoeae, causing skin lesions (often pustular or necrotic), plus synovitis of major joints (such as knee, ankle, elbow), and tendon sheaths. (05 Mar 2000) |
| tenosynovitis | <pathology> Inflammation of a tendon sheath. (18 Nov 1997) |
| localised nodular tenosynovitis | A nodule, possibly inflammatory in nature, arising commonly from the flexor sheath of the fingers and thumb; composed of fibrous tissue, lipid-and haemosiderin-containing macrophages, and multinucleated giant cells. Synonym: localised nodular tenosynovitis. (05 Mar 2000) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| autogenous vaccine | A vaccine made from a culture of the patient's own bacteria. (05 Mar 2000) |
| bacillus Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| BCG vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| brucella strain 19 vaccine | A live bacterial vaccine prepared from an attenuated variant strain of Brucella abortus (strain 19); used for vaccinating cattle against brucellosis. (05 Mar 2000) |
| brucella vaccine | A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats. (12 Dec 1998) |
| Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|